University of Utah - Huntsman Cancer Institute - PPDS is a clinical research site located in Salt Lake City, Utah, United States 84112-5550.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Utah - Huntsman Cancer Institute - PPDS has participated in 6 clinical trials with 2 currently active.
Therapeutic areas: Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation.
Sponsors: Pierre Fabre Medicament, Bristol-Myers Squibb, Blueprint Medicines Corporation.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Utah - Huntsman Cancer Institute - PPDS has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Utah - Huntsman Cancer Institute - PPDS has 6 clinical trials on record, with 2 currently active. Their work covers Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation.
Yes — University of Utah - Huntsman Cancer Institute - PPDS holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.